Literature DB >> 11072782

Relationship between the morphological and biological characteristics of intraductal components accompanying invasive ductal breast carcinoma and patient age.

H Imamura1, S Haga, T Shimizu, O Watanabe, J Kinoshita, H Nagumo, T Kajiwara, M Aiba.   

Abstract

We divided 324 cases with invasive ductal breast carcinoma into three age groups, and investigated the differences in proliferative activity and extension of the intraductal components among the age cohorts. Proliferative activity was expressed as the number of MIB1-positive nuclei per 1000 cancer cells in the intraductal components (MLI), and the intraductal component extension farthest from the invasive focus was defined as the maximum distance of ductal spread (MXDS). Moreover, analyses were conducted for three grade types, classified according to the classification system of ductal carcinoma in situ. The under-40 age group had significantly higher MXDS values than the other two age groups (p = 0.0280), and this trend was more marked in those with the non-high grade without necrosis type (p = 0.0045). The under-40 age group had higher MLIs, but the differences did not reach statistical significance (p = 0.0793). In regard to those with the high grade type, the under-40 age group had significantly higher MLIs than the other two age groups (p = 0.0269), and this trend was not significant in the cases with any other grade types. Associations between the age group and the margin status of the lumpectomy specimens were investigated in the 143 cases in which breast conserving surgery was tried. The under-40s had a significantly higher margin-positive rate in their lumpectomy specimens than the other two age groups (= 0.0362), and this trend was also seen in the groups with the non-high grade without necrosis type (p = 0.0256). These results confirm the importance of considering patient age when designing surgical procedures for breast conserving therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11072782     DOI: 10.1023/a:1006462328544

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  11 in total

Review 1.  Hypofractionated breast irradiation: a multidisciplinary review of the Senonetwork study group.

Authors:  Bruno Meduri; Fiorenza De Rose; Carlo Cabula; Isabella Castellano; Lucia Da Ros; Massimo Maria Grassi; Sandra Orrù; Fabio Puglisi; Rubina Manuela Trimboli; Antonella Ciabattoni
Journal:  Med Oncol       Date:  2021-05-10       Impact factor: 3.064

2.  Impact of the presence and quantity of ductal carcinoma in situ component on the outcome of invasive breast cancer.

Authors:  Carla Cedolini; Serena Bertozzi; Ambrogio P Londero; Luca Seriau; Michela Andretta; Diane Agakiza; Sandro Fongione; Alessandro Uzzau; Andrea Risaliti
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients.

Authors:  Laura C Collins; Ninah Achacoso; Larissa Nekhlyudov; Suzanne W Fletcher; Reina Haque; Charles P Quesenberry; Balaram Puligandla; Najeeb S Alshak; Lynn C Goldstein; Allen M Gown; Stuart J Schnitt; Laurel A Habel
Journal:  Am J Surg Pathol       Date:  2009-12       Impact factor: 6.394

Review 4.  Accelerated partial breast irradiation after conservative surgery for breast cancer.

Authors:  Henry M Kuerer; Thomas B Julian; Eric A Strom; H Kim Lyerly; Armando E Giuliano; Eleftherios P Mamounas; Frank A Vicini
Journal:  Ann Surg       Date:  2004-03       Impact factor: 12.969

Review 5.  Accelerated Partial Breast Irradiation (APBI): A review of available techniques.

Authors:  Christopher F Njeh; Mark W Saunders; Christian M Langton
Journal:  Radiat Oncol       Date:  2010-10-04       Impact factor: 3.481

Review 6.  Synchronous bilateral breast cancer patients submitted to conservative treatment and brachytherapy - The experience of a service.

Authors:  Joana Pinheiro; Darlene Rodrigues; Pedro Fernandes; Alexandre Pereira; Lurdes Trigo
Journal:  Rep Pract Oncol Radiother       Date:  2018-08-13

Review 7.  Accelerated partial breast irradiation: the case for current use.

Authors:  Martin E Keisch
Journal:  Breast Cancer Res       Date:  2005-04-05       Impact factor: 6.466

Review 8.  Current Controversies on the Use of Magnetic Resonance Imaging in the Management of Breast Cancer.

Authors:  Edibaldo Silva
Journal:  World J Oncol       Date:  2011-06-08

9.  Impact of interfraction seroma collection on breast brachytherapy dosimetry - a mathematical model.

Authors:  Aashish Bhatt; Keith Sowards; Geetika Bhatt; Andrew Freeman; Anthony Dragun
Journal:  J Contemp Brachytherapy       Date:  2012-06-30

10.  On the feasibility of treating to a 1.5 cm PTV with a commercial single-entry hybrid applicator in APBI breast brachytherapy.

Authors:  Kent A Gifford; Christopher L Nelson; Steven M Kirsner; Kelly D Kisling; Matthew T Ballo; Elizabeth S Bloom
Journal:  J Contemp Brachytherapy       Date:  2012-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.